The new implantable device utilizes engineered protein producers to continuously deliver vital biologic medications.
Live Poll
Do you believe new medical innovations will effectively lower your long-term healthcare costs?
October 1, 2026
CTMC Began Pivotal TIL Manufacturing in HoustonThe Houston-based company has launched a partner program for tumor-infiltrating lymphocyte therapy production.
September 30, 2026
Baylor Researchers Identified VAV1 Degrader CompoundsThe study reveals new molecular glue compounds capable of degrading the VAV1 protein implicated in disease.
September 22, 2026
Eos SENOLYTIX Announced Keynote for Mitochondria CongressThe Houston-based biotech firm prepares for a major industry presentation ahead of its upcoming merger vote.
